Genelux Corporation (GNLX) vs LENZ Therapeutics, Inc. (LENZ)
A side-by-side comparison of Genelux Corporation and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GNLX
Genelux Corporation
$2.60HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
LENZ
LENZ Therapeutics, Inc.
$3.80HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — GNLX vs LENZ
growth of $100 · dividends reinvested · last 4yGNLX -57.7% (-19.4%/yr)LENZ -16.4% (-4.4%/yr)LENZ compounded faster over this window
GNLX LENZ
GNLX vs LENZ: by the numbers
- •LENZ is the larger company ($119M vs $116M market cap).
- •Both run net losses; LENZ's is the smaller (-586.74% vs -422412.50% net margin).
Metrics side by side
Valuation
| Metric | GNLX | LENZ |
|---|---|---|
| P/S ratio | 14545.11 | 5.54 |
| P/B ratio | 7.22 | 0.54 |
Profitability
| Metric | GNLX | LENZ |
|---|---|---|
| Gross margin | -7075.00% | 90.14% |
| Operating margin | -415175.00% | -477.46% |
| Net margin | -422412.50% | -586.74% |
| ROE | -209.73% | -57.47% |
| ROIC | -192.18% | -61.84% |
Growth (annualized)
| Metric | GNLX | LENZ |
|---|---|---|
| Total return CAGR (5Y) | N/A | -35.49% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.